Skip to content

Combining Chinese Medicine and Nutrition to Enhance Weight Loss After Bariatric Surgery

Combining Chinese Medicine and Nutrition to Enhance Weight Loss After Bariatric Surgery

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06419764
Enrollment
120
Registered
2024-05-17
Start date
2024-02-01
Completion date
2025-07-31
Last updated
2024-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traditional Chinese Medicine Treatment, Weight Change

Brief summary

This study aims to investigate the effects of Chinese herbal granule preparations on improving gastrointestinal symptoms in patients after bariatric surgery. It seeks to establish a novel treatment model that combines bariatric surgery with traditional Chinese medicine, providing clinical practice with additional evidence-based medical support.

Interventions

DRUGSpleen Invigorating and Weight Reducing Decoction

Composition: Raw Astragalus (Huang Qi) 5g, Cang Zhu 5g, Fructus Aurantii Immaturus (Zhi Shi) 3g, Prepared Rhubarb (Shu Jun) 3g, Red Peony Root (Chi Shao Yao) 3g, Crataegus (Shan Zha) 3g, Tribulus (Bai Jie Li) 2g, Cimicifuga (Sheng Ma) 1g. Granule form, for oral administration. Take 1 dose daily (2 bags, once in the morning and once in the evening, dissolved in water), for a course of 1 month.

OTHERDiet and meal replacements

The dietitian provides recommended meal plans based on body weight, and meal replacements are used postoperatively.

Sponsors

China-Japan Friendship Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. BMI ≥ 27.5 kg/m²; 2. Undergoing metabolic bariatric surgery; 3. Traditional Chinese Medicine syndrome differentiation classified as Spleen Deficiency and Excess Dampness syndrome.

Exclusion criteria

1. Contraindications for metabolic bariatric surgery; 2. Type 1 diabetes; 3. Complicated by other significant systemic diseases, such as severe liver and kidney diseases, malignant tumors, psychiatric disorders, etc; 4. Concurrent use of other medications or treatments that may affect body weight, such as metformin, semaglutide, endoscopic interventions, etc; 5. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Percentage change in body weightBefore bariatric surgery, 1 month after surgery, and 3 months after surgery.

Secondary

MeasureTime frameDescription
Traditional Chinese Medicine syndrome scoreBefore bariatric surgery, 1 month after surgery, and 3 months after surgery.
blood glucose indicatorsBefore bariatric surgery, 1 month after surgery, and 3 months after surgery.HbA1c, blood glucose, insulin levels
blood lipid profileBefore bariatric surgery, 1 month after surgery, and 3 months after surgery.total cholesterol, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol

Countries

China

Contacts

Primary ContactHuang Yishan, doctor
bucmyishan@163.com18810621201
Backup ContactMeng Hua, doctor
menghuade@hotmail.com18611457779

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026